Anderson Schock
Stock Analyst at B. Riley Securities
(1.29)
# 3,502
Out of 4,423 analysts
35
Total ratings
46.7%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintained: Buy | $20 → $30 | $17.77 | +68.82% | 5 | Jun 17, 2026 | |
| VREX Varex Imaging | Reiterated: Buy | $18 | $10.54 | +70.78% | 4 | May 28, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $3.99 | +150.63% | 1 | May 18, 2026 | |
| ELMD Electromed | Maintained: Buy | $38 → $40 | $38.68 | +3.41% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Maintained: Buy | $11 → $10 | $4.98 | +100.80% | 4 | May 13, 2026 | |
| TCMD Tactile Systems Technology | Upgraded: Buy | $32 → $36 | $26.62 | +35.24% | 4 | May 7, 2026 | |
| BEAT HeartBeam | Initiated Coverage: Buy | $4 | $0.7596 | +426.59% | 1 | Mar 31, 2026 | |
| XGN Exagen | Maintained: Buy | $8 | $4.54 | +76.21% | 4 | Mar 11, 2026 | |
| ANIK Anika Therapeutics | Maintained: Buy | $16 → $18 | $14.40 | +25.00% | 3 | Feb 26, 2026 | |
| SPOK Spok Holdings | Downgraded: Hold | $14 | $10.51 | +33.21% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.86 | +168.82% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.41 | +118.41% | 3 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.42 | +27.39% | 2 | Nov 5, 2025 |
ClearPoint Neuro
Jun 17, 2026
Maintained: Buy
Price Target: $20 → $30
Current: $17.77
Upside: +68.82%
Varex Imaging
May 28, 2026
Reiterated: Buy
Price Target: $18
Current: $10.54
Upside: +70.78%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $3.99
Upside: +150.63%
Electromed
May 13, 2026
Maintained: Buy
Price Target: $38 → $40
Current: $38.68
Upside: +3.41%
OptimizeRx
May 13, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $4.98
Upside: +100.80%
Tactile Systems Technology
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $26.62
Upside: +35.24%
HeartBeam
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.7596
Upside: +426.59%
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.54
Upside: +76.21%
Anika Therapeutics
Feb 26, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $14.40
Upside: +25.00%
Spok Holdings
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.51
Upside: +33.21%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $6.41
Upside: +118.41%
Nov 5, 2025
Maintained: Buy
Price Target: $12
Current: $9.42
Upside: +27.39%